Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-28T13:40:47.941Z Has data issue: false hasContentIssue false

Trends in Stenotrophomonas maltophilia Bloodstream Infection in Relation to Usage Density of Cephalosporins and Carbapenems During 7 Years

Published online by Cambridge University Press:  02 January 2015

Jorge G. Paez
Affiliation:
Department of Infectious Diseases, University of São Paulo Medical School, São Paulo, SP, Brazil
Anna S. Levin
Affiliation:
Department of Infectious Diseases, University of São Paulo Medical School, São Paulo, SP, Brazil
Mariusa Basso
Affiliation:
Department of Infectious Diseases, University of São Paulo Medical School, São Paulo, SP, Brazil
Laura B. Gomez
Affiliation:
Department of Infectious Diseases, University of São Paulo Medical School, São Paulo, SP, Brazil
Satiko Gobara
Affiliation:
Department of Infectious Diseases, University of São Paulo Medical School, São Paulo, SP, Brazil
Fernanda Spadão
Affiliation:
Department of Infectious Diseases, University of São Paulo Medical School, São Paulo, SP, Brazil
Isabel Oshiro
Affiliation:
Department of Infectious Diseases, University of São Paulo Medical School, São Paulo, SP, Brazil
Silvia Figueiredo Costa*
Affiliation:
Department of Infectious Diseases, University of São Paulo Medical School, São Paulo, SP, Brazil
*
Department of Infectious Diseases, Hospital das Clinicas of University of São Paulo, Av. Enéas de Carvalho Aguiar, n° 500-2°, Andar LIM54, CEP:05410-000, São Paulo, Brazil ([email protected])
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2008

References

1.Sanyal, SC, Mokaddas, EM. The increase in carbapenem use and emergence of Stenotrophomonas maltophilia as an important nosocomial pathogen. J Chemother 1999;11:2833.Google Scholar
2.Del Toro, MD, Rodriguez-Baño, J, Herrero, M, et al.Clinical epidemiology of Stenotrophomonas maltophilia colonization and infection. Medicine 2002;81:228239.Google Scholar
3.Carmeli, Y, Samore, H. Comparison of treatment with imipenem vs. ceftazidime as a predisposing factor for nosocomial acquisition of Stenotrophomonas maltophilia: a historical cohort study. Clin Infect Dis 1997;24:11311134.Google Scholar
4.Meyer, E, Schwab, F, Gastmeier, P, Rüden, H, Daschner, FD. Is the prevalence of Stenotrophomonas maltophilia isolation and nosocomial infection increasing in intensive care units? Eur J Clin Microbiol Infect Dis 2006;25:711714Google Scholar
5.Jones, RN, Sader, HS, Beach, ML. Contemporary in vitro spectrum of activity summary for antimicrobial agents tested against 18,569 strains of non-fermentative gram-negative bacilli isolated in the SENTRY Antimicrobial Surveillance Program (1997–2001). Int J Antimicrob Agents 2003;22:551556.Google Scholar
6.World Health Organization Collaborating Center For Drug Statistic Methodology. Anatomical Therapeutic Chemical (ATC) classification index with defined daily dose (DDD). 2008. Available at: http://www.whocc.no/atcddd/.Google Scholar
7.Krcmery, V Jr, Sykora, P, Trupl, J, et al.Antibiotic use and development of resistance in blood culture isolates: 8 years of experience from a cancer center. J Chemother 2001;13:133142.Google Scholar
8.Metan, G, Hayran, M, Hascelik, G, Uzun, O. Which patient is a candidate for empirical therapy against Stenotrophomonas maltophilia bacteraemia? An analysis of associated risk factors in a tertiary care hospital. Scand J Infect Dis 2006;38:527531.Google Scholar